+56,668.7%
NVDA vs ABBV
+1,359.4%
+55,309.3%
-66.3%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ABBV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.3% | -0.2% | -4.2% | -4.3% |
| 7D | -8.5% | +2.2% | -10.6% | -9.1% |
| 30D | -27.3% | +8.0% | -35.3% | -29.0% |
| 3M | -25.8% | +19.1% | -44.8% | -29.7% |
| 6M | -24.6% | +43.5% | -68.1% | -33.1% |
| YTD | -10.7% | +32.7% | -43.4% | -19.2% |
| 1Y | -14.0% | +30.0% | -44.1% | -21.8% |
| 3Y | +244.9% | +134.7% | +110.1% | +145.8% |
| 5Y | +449.3% | +200.6% | +248.6% | +245.7% |
| 10Y | +7,600.6% | +601.3% | +6,999.3% | +3,499.9% |
| All | +56,668.7% | +1,359.4% | +55,309.3% | +23,315.5% |
Cumulative growth
Daily Returns
Daily percentage return beside ABBV.
Daily Out/Under-Performance
Portfolio return minus ABBV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ABBV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ABBV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling